GSK5471713

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK5471713, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: First-Time-in-Human Study of GSK5471713 in Adults With mCRPC [Phase 1, Phase 2]